Telma D Tablet

Telma D Tablet

Prescription requiredRx Required

Salt Composition: Telmisartan (40mg) + Indapamide (1.5mg)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

10 Tablet

About The Product

Effective In Salt-Sensitive And Elderly Hypertensive Patients

Description

Telma D tablet is a hypersensitivity medication which is used in treatment of high blood pressure with a combinations of two drugs. The medicine contains Temisartan in 40mg concentration and Indapamide in 1.5mg concentration that belongs to the drug class of anti hypertensive agents.

It works in lowering high blood pressure (hypertension) by relaxing blood vessels and reducing fluid retention. The medicine should be taken under doctor prescription to ensure safe and effective treatment.

Dosage and duration of the medication should be correctly determined by a doctor based on the patient's condition, blood pressure levels and response to the treatment.

Uses

Manage high blood pressure

Side Effects

Telma D tablet cause certain side effects, some are mild and some are acute. Consider the treatment option based on the symptoms.

Here are the following side effects:

  • Headache
  • Dizziness
  • Weakness
  • Stomach pain
  • Constipation
  • Infection
  • Inflammation of the nose
  • Chest pain
  • Back pain
  • Indigestion
  • Nervousness
  • Hypertonia
  • Peripheral edema
  • Sore throat
  • Cough
  • Severe skin reaction
  • Kidney disease

How To Use

  • Telma D Tablet should be taken orally with or without food at the fixed time everyday to enhance the treatment effectiveness.
  • Do not crush, chew or break the tablet just swallow it with whole glass of water to ensure proper absorption of the medication and maintain its effectiveness in controlling blood pressure.
  • Always follow doctor's guidance to ensure safe and effective treatment.

How It Works

Telma D tablet contains two active drugs that lower blood pressure effectively. The medication is slowly blocking the binding of angiotensin II to the AT1 receptor found in vascular smooth muscle. By inhibiting this receptor, telmisartan prevents blood vessels tightening effects of the hormone, leading to widening of blood vessels.

While Indapamide works in the kidney tubules to increase the excretion of sodium, chloride and water. This reduction in blood volume reduces the strain on the heart and allowing it to pump more efficiently.


Safety Advice

Alcohol
Taking alcohol while using a Telma D tablet may be harmful and may cause serious health concern. Consult the healthcare professional to ensure safety during the treatment.
Pregnancy
Pregnant women should consult the doctor before taking Telma D tablet as it can harm the developing baby.
Breast Feeding
Telma D tablet should not recommended to breastfeed women as the medicine is passing through breast which affect the baby in many ways.
Driving
Avoid driving if any of these symptoms persist such as eye vision, cause dizziness and weakness while taking Telma D tablet.
Kidney
Telma D tablet should be used with caution in patients of kidney disease. Dose adjustment must be needed to avoid complications during the treatment.
Liver
Telma D is unsafe to use in patients with liver disease as this may interfere with the liver function. Consult the healthcare provider about the correct dose and duration of the treatment.

FAQs

Yes, heart patient may use Telma D tablet but if it is only prescribed by the doctor.

As the dosage and suitability depend on the individual’s medical condition.

References

  • Chaffman, M., Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1984). Indapamide: a review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs, 28(3), 189-235 - https://pubmed.ncbi.nlm.nih.gov/6489195/
  • Sassard, J., Bataillard, A., & McIntyre, H. (2005). An overview of the pharmacology and clinical efficacy of indapamide sustained release. Fundamental & clinical pharmacology, 19(6), 637-645 - https://pubmed.ncbi.nlm.nih.gov/16313275/
  • Robinson, D. M., & Wellington, K. (2006). Indapamide sustained release: a review of its use in the treatment of hypertension. Drugs, 66(2), 257-271 - https://pubmed.ncbi.nlm.nih.gov/16451099/
  • McClellan, K. J., & Markham, A. (1998). Telmisartan. Drugs, 56(6).
  • Sharpe, M., Jarvis, B., & Goa, K. L. (2001). Telmisartan: a review of its use in hypertension. Drugs, 61(10), 1501-1529.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026